glp-1 therapy thibodaux Weight Loss Medication Understand GLP-1/GIP Dual Agonist Tirzepatide

A., & Tafuri, S

This can show up as symptoms such as delayed growth and development (failure to thrive), regression in neuromotor skills (such as losing the ability to roll over or grasp objects), failure to maintain eye contact (even in an infant who previous could do so), general muscle weakness, lethargy, excessive sleepiness, feeding difficulties, and even brain shrinkage

NHS access requires referral to specialist weight management services, meeting specific BMI and comorbidity criteria as outlined in NICE guidance

conversely, the diagnosis is frequently delayed in patients with NF1 due to potential misdiagnosis of these lesions as classical neurofibroma and/or plexiform neurofibroma [20]